KLF5 and prostate cancer: Conversely, Ci et al. (2015) found that overexpression of KLF5 repressed the expression of HIF-1α, VEGF, PDGF-A, and PDGF-B, thus exerting an anti-angiogenetic and anti-proliferative effects in prostate cancer.